Terumo Blood and Cell Technologies

QUICK LINKS

Get Product Support Find Technical Documents Find Certificates of Compliance Get Training Start a Career With Us Distributor News Modern Slavery Act Statement Community Letter - Ethylene Oxide (EtO)

LATEST NEWS

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.

Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.

Meet the TRI: Industry Influencers

Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions

{{$index+1}}. {{s.label}}

Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers
Read More.

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.
Read More.

Quantum Flex^® Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.

Making hope tangible for cell and gene therapies. Watch now

Meet the TRI: Industry Influencers

Terumo Blood and Cell Technologies Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Pete is alive today because of plasma donors.
Watch Now.

Quantum Flex, the next generation of cell expansion has arrived

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

LATEST NEWS

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.

Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.

Meet the TRI: Industry Influencers

Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions

Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers Read More.

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies. Read More.

Quantum Flex® Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD® WB Platelet Pooling Set cleared by FDA, officially launched.

Making hope tangible for cell and gene therapies. Watch now

Meet the TRI: Industry Influencers

Terumo Blood and Cell Technologies Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Pete is alive today because of plasma donors. Watch Now.

Quantum Flex, the next generation of cell expansion has arrived

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

LATEST NEWS

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.

Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD® WB Platelet Pooling Set cleared by FDA, officially launched.

Meet the TRI: Industry Influencers

Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions

Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers
Read More.

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.
Read More.

Quantum Flex^® Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.

Pete is alive today because of plasma donors.
Watch Now.

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.